Advanced Medical Solutions Group - Public Comps and Valuation Multiples

Advanced Medical Solutions Group Overview

About Advanced Medical Solutions Group

Advanced Medical Solutions Group PLC is engaged in developing, and manufacturing advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical; and Woundcare, of which Surgical segment derives maximum revenue.

Founded

1993

HQ

Employees

1.6K+

Website

admedsol.com

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $291M

LTM EBITDA $64.1M

EV

$731M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Advanced Medical Solutions Group Financials

As of September 2025, Advanced Medical Solutions Group reported last 12-month revenue of $291M and EBITDA of $64.1M.

In the same period, Advanced Medical Solutions Group generated $154M in LTM gross profit and $30.6M in net income.

See Advanced Medical Solutions Group valuation multiples based on analyst estimates

Advanced Medical Solutions Group P&L

In the most recent fiscal year, Advanced Medical Solutions Group reported revenue of $237M and EBITDA of $39.4M.

Advanced Medical Solutions Group expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Advanced Medical Solutions Group valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$291M	XXX	$237M	XXX	XXX	XXX
Gross Profit	$154M	XXX	$123M	XXX	XXX	XXX
Gross Margin	53%	XXX	52%	XXX	XXX	XXX
EBITDA	$64.1M	XXX	$39.4M	XXX	XXX	XXX
EBITDA Margin	22%	XXX	17%	XXX	XXX	XXX
EBIT	$43.2M	XXX	$29.5M	XXX	XXX	XXX
EBIT Margin	15%	XXX	12%	XXX	XXX	XXX
Net Profit	$30.6M	XXX	$9.5M	XXX	XXX	XXX
Net Margin	11%	XXX	4%	XXX	XXX	XXX
Net Debt	XXX	XXX	$74.4M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Advanced Medical Solutions Group including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $291M. EBITDA for the last twelve months was $64.1M. In the most recent fiscal year, Advanced Medical Solutions Group achieved $237M in revenue and $39.4M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$291M	Analyst estimates available to subscribers	$237M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$154M	Analyst estimates available to subscribers	$123M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	52.8% gross margin	Analyst estimates available to subscribers	52.2% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$64.1M	Analyst estimates available to subscribers	$39.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	22.0% EBITDA margin	Analyst estimates available to subscribers	16.6% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$43.2M	Analyst estimates available to subscribers	$29.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	14.8% EBIT margin	Analyst estimates available to subscribers	12.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$30.6M	Analyst estimates available to subscribers	$9.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	10.5% net profit margin	Analyst estimates available to subscribers	4.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$74.4M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Advanced Medical Solutions Group

This financial data table provides comprehensive performance metrics for Advanced Medical Solutions Group, a company based in United Kingdom of Great Britain and Northern Ireland. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Advanced Medical Solutions Group generated $291M in revenue over the last twelve months.
The company achieved $64.1M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $154M.
Net income over the last twelve months reached $30.6M.

Fiscal Year Performance

In the most recent fiscal year, Advanced Medical Solutions Group reported $237M in total revenue.
Fiscal year EBITDA was $39.4M.
The company maintained a gross profit margin of 52.2% in the most recent fiscal year.
EBITDA margin for the fiscal year was 16.6%.
Net profit margin reached 4.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Advanced Medical Solutions Group. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Advanced Medical Solutions Group Stock Performance

Advanced Medical Solutions Group has current market cap of GBP 485M (or $647M), and EV of GBP 548M (or $731M).

Market Cap Evolution

Advanced Medical Solutions Group Stock Data

As of October 17, 2025, Advanced Medical Solutions Group's stock price is GBP 2 (or $3).

See Advanced Medical Solutions Group trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$731M	$647M	XXX	XXX	XXX	XXX	$0.15

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Advanced Medical Solutions Group Valuation Multiples

Advanced Medical Solutions Group's trades at 3.1x EV/Revenue multiple, and 18.6x EV/EBITDA.

See valuation multiples for Advanced Medical Solutions Group and 15K+ public comps

Advanced Medical Solutions Group Financial Valuation Multiples

As of October 17, 2025, Advanced Medical Solutions Group has market cap of $647M and EV of $731M.

Equity research analysts estimate Advanced Medical Solutions Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Advanced Medical Solutions Group has a P/E ratio of 21.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$647M	XXX	$647M	XXX	XXX	XXX
EV (current)	$731M	XXX	$731M	XXX	XXX	XXX
EV/Revenue	2.5x	XXX	3.1x	XXX	XXX	XXX
EV/EBITDA	11.4x	XXX	18.6x	XXX	XXX	XXX
EV/EBIT	16.9x	XXX	24.8x	XXX	XXX	XXX
EV/Gross Profit	4.8x	XXX	n/a	XXX	XXX	XXX
P/E	21.1x	XXX	68.4x	XXX	XXX	XXX
EV/FCF	35.1x	XXX	51.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Advanced Medical Solutions Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Advanced Medical Solutions Group Margins & Growth Rates

Advanced Medical Solutions Group's last 12 month revenue growth is 11%

Advanced Medical Solutions Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Advanced Medical Solutions Group's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Advanced Medical Solutions Group's rule of X is 48% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Advanced Medical Solutions Group and other 15K+ public comps

Advanced Medical Solutions Group Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	11%	XXX	17%	XXX	XXX	XXX
EBITDA Margin	22%	XXX	17%	XXX	XXX	XXX
EBITDA Growth	13%	XXX	24%	XXX	XXX	XXX
Rule of 40	36%	XXX	27%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	48%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	40%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial